ArticleFrontiers in cardiovascular medicine2025
Interventional treatment for pulmonary venous stenosis due to fibrosing mediastinitis: a case report.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Acute mediastinitis, mediastinal granuloma, and fibrosing mediastinitis: a narrative review.Mediastinum (Hong Kong, China) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Fibrosing mediastinitis is a rare syndrome caused by the abnormal proliferation of mediastinal fibrous tissue. It often causes superior vena cava syndrome, bronchial stenosis, pulmonary vascular stenosis, etc. Patient presentation: An elderly male patient presented with intermittent chest tightness, shortness of breath, cough, and large pleural effusion. He was diagnosed with fibrosing mediastinitis through echocardiography, chest CT, and inflammatory indicators. Contrast-enhanced CT and selective angiography showed severe stenosis of multiple branches of bilateral pulmonary veins. The patient is considered to have pulmonary vein stenosis caused by FM, and for further treatment, we performed two interventional therapies at different times. After two operations, the stenosis of bilateral multiple pulmonary veins in this patient has been relieved. Additionally, we also discovered that for pulmonary vein stenosis caused by FM, stent implantation is more effective than balloon dilation. Conclusion: This case report confirmed that interventional treatment for pulmonary vein stenosis is safe and effective. This study also provides a potential treatment approach for pulmonary vein stenosis resulting from fibrosing mediastinitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.